What Happened

A federal judge approved a consent decree between the United States and Beckman's Greene Street Pharmacy in Cumberland, Maryland, resolving allegations that the pharmacy filled fraudulent opioid prescriptions for years while ignoring documented red flags.

The government alleged that since at least 2017, pharmacist John A. Beckman and Beckman's Pharmacy knowingly filled fraudulent controlled-substance prescriptions despite warning signs the prescriptions were not legitimate. Prescriptions regularly combined an opioid with a benzodiazepine and carisoprodol — the dangerous "holy trinity" combination — or paired opioids with buprenorphine, and were often paid for in cash even when the patient had insurance available. The pharmacy routinely dispensed doses causing patients' morphine milligram equivalents to run many times above the CDC's recommended ceiling, up to roughly 1,000 MME per day.

The government further alleged that Beckman's Pharmacy dispensed opioids to more than ten patients who died within ten days of the date of their opioid prescription. Under the consent decree — approved in July 2023 and the fourth such decree in the District of Maryland in two years — the pharmacy agreed to pay a $120,000 civil monetary penalty, adopt a red-flag identification and documentation protocol, and accept restrictions on filling specific high-risk prescription combinations, including any prescription for a pharmacy employee.

What Went Wrong

A retail pharmacy filled high-risk prescriptions for years without a documented process to catch or resolve red flags. Key failures included:

  • Dangerous combination prescriptions — opioid-benzodiazepine-carisoprodol and opioid-buprenorphine — were filled without any documented clinical justification.
  • Cash payment despite available insurance, a classic diversion red flag, did not trigger additional scrutiny before dispensing.
  • Daily MME levels many times above CDC guidance were dispensed routinely rather than being capped or escalated for pharmacist review.
  • No internal protocol required documenting how the pharmacy resolved red flags before filling a flagged prescription.

How It Could Have Been Prevented

  • Require documented resolution of specific red flags — high MME, dangerous combinations, cash payment despite insurance, long travel distance — before filling any flagged prescription.
  • Set a hard MME ceiling that requires pharmacist-in-charge sign-off and prescriber contact before dispensing above it.
  • Flag opioid-benzodiazepine-carisoprodol and opioid-buprenorphine combinations for mandatory clinical review rather than routine fill.
  • Audit dispensing records against DEA red-flag guidance on a recurring schedule, independent of any external investigation.

Related Guidance

Sources